PSA in the New Millennium: A Powerful Predictor of Prostate Cancer Prognosis and Radical Prostatectomy Outcomes — Results from the SEARCH Database-Reference-Cited by-同舟云学术

PSA in the New Millennium: A Powerful Predictor of Prostate Cancer Prognosis and Radical Prostatectomy Outcomes — Results from the SEARCH Database

Published:2008-04 Issue:4 Volume:53 Page:758-766
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Freedland Stephen J.,Hotaling James M.,Fitzsimons Nicholas J.,Presti Joseph C.,Kane Christopher J.,Terris Martha K.,Aronson William J.,Amling Christopher L.

Publisher

Elsevier BV

Subject

Urology

Reference26 articles.

1. Stanford JL, Stephenson RA, Coyle LM, et al. Prostate cancer trends 1973–1995; SEER program, National Cancer Institute NIH publication no. 99-4543. Bethesda, MD: 1999.

2. Self-reported prostate cancer screening in Austria;Vutuc;J Med Screen,2006

3. Extent of prostate-specific antigen contamination in the Spanish section of the European Randomized Study of Screening for Prostate Cancer (ERSPC);Luján;Eur Urol,2006

4. Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0ng/ml or lower;Thompson;JAMA,2005

5. The prostate specific antigen era in the united states is over for prostate cancer: What happened in the last 20 years?;Stamey;J Urol,2004

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoantibodies Targeting Prostate-specific Antigen: Implications in Prostate Cancer – A Narrative Review;Oncology Journal of India;2024-05

2. A population-based propensity score matching analysis of risk factors and the impact on survival associated with refusal of cancer-directed surgery in patients with prostate cancer;Scientific Reports;2024-04-25

3. New approaches and prospects of immunotherapy and gene therapy for prostate cancer;Journal of Translational Genetics and Genomics;2024-03-29

4. Mortality reduction and cumulative excess incidence (CEI) in the prostate-specific antigen (PSA) screening era;Scientific Reports;2024-03-09

5. Survival outcomes of patients treated with local therapy for nonmetastatic prostate cancer with high prostate‐specific antigen concentrations;The Prostate;2023-08-07